 | • レポートコード：GIR-2104Z11463 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、処方皮膚科治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。処方皮膚科治療の種類別市場規模（真菌感染症薬、皮膚がん薬、にきび＆酒皶薬、乾癬薬、皮膚炎＆脂漏症薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・処方皮膚科治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、AbbVie、Johnson & Johnson、Novartis、Amgen、Eli Lilly、Celgene、LEO Pharma、Bausch Health Companies、Sun Pharmaceutical、Aclaris Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：真菌感染症薬、皮膚がん薬、にきび＆酒皶薬、乾癬薬、皮膚炎＆脂漏症薬 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・処方皮膚科治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・処方皮膚科治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・処方皮膚科治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・処方皮膚科治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・処方皮膚科治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prescription Dermatology Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prescription Dermatology Therapeutics size is estimated to be USD 32930 million in 2025 from USD 26930 million in 2019, with a change XX% between 2019 and 2020. The global Prescription Dermatology Therapeutics market size is expected to grow at a CAGR of 5.2% for the next five years.
Market segmentation
Prescription Dermatology Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fungal Infection Drugs
Skin Cancer Drugs
Acne & Rosacea Drugs
Psoriasis Drugs
Dermatitis & Seborrhea Drugs
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Pfizer
AbbVie
Johnson & Johnson
Novartis
Amgen
Eli Lilly
Celgene
LEO Pharma
Bausch Health Companies
Sun Pharmaceutical
Aclaris Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Prescription Dermatology Therapeutics
1.2 Classification of Prescription Dermatology Therapeutics by Type
1.2.1 Overview: Global Prescription Dermatology Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prescription Dermatology Therapeutics Revenue Market Share by Type in 2020
1.2.3 Fungal Infection Drugs
1.2.4 Skin Cancer Drugs
1.2.5 Acne & Rosacea Drugs
1.2.6 Psoriasis Drugs
1.2.7 Dermatitis & Seborrhea Drugs
1.3 Global Prescription Dermatology Therapeutics Market by Application
1.3.1 Overview: Global Prescription Dermatology Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Prescription Dermatology Therapeutics Market Size & Forecast
1.5 Global Prescription Dermatology Therapeutics Market Size and Forecast by Region
1.5.1 Global Prescription Dermatology Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prescription Dermatology Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Prescription Dermatology Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Prescription Dermatology Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prescription Dermatology Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Prescription Dermatology Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prescription Dermatology Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prescription Dermatology Therapeutics Market Drivers
1.6.2 Prescription Dermatology Therapeutics Market Restraints
1.6.3 Prescription Dermatology Therapeutics Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Prescription Dermatology Therapeutics Product and Solutions
2.1.4 Pfizer Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Prescription Dermatology Therapeutics Product and Solutions
2.2.4 AbbVie Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AbbVie Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Product and Solutions
2.3.4 Johnson & Johnson Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Prescription Dermatology Therapeutics Product and Solutions
2.4.4 Novartis Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Prescription Dermatology Therapeutics Product and Solutions
2.5.4 Amgen Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Amgen Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Prescription Dermatology Therapeutics Product and Solutions
2.6.4 Eli Lilly Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Celgene
2.7.1 Celgene Details
2.7.2 Celgene Major Business
2.7.3 Celgene Prescription Dermatology Therapeutics Product and Solutions
2.7.4 Celgene Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Celgene Recent Developments and Future Plans
2.8 LEO Pharma
2.8.1 LEO Pharma Details
2.8.2 LEO Pharma Major Business
2.8.3 LEO Pharma Prescription Dermatology Therapeutics Product and Solutions
2.8.4 LEO Pharma Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 LEO Pharma Recent Developments and Future Plans
2.9 Bausch Health Companies
2.9.1 Bausch Health Companies Details
2.9.2 Bausch Health Companies Major Business
2.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Product and Solutions
2.9.4 Bausch Health Companies Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bausch Health Companies Recent Developments and Future Plans
2.10 Sun Pharmaceutical
2.10.1 Sun Pharmaceutical Details
2.10.2 Sun Pharmaceutical Major Business
2.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Product and Solutions
2.10.4 Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sun Pharmaceutical Recent Developments and Future Plans
2.11 Aclaris Therapeutics
2.11.1 Aclaris Therapeutics Details
2.11.2 Aclaris Therapeutics Major Business
2.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Product and Solutions
2.11.4 Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Aclaris Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prescription Dermatology Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Prescription Dermatology Therapeutics Players Market Share
3.2.2 Top 10 Prescription Dermatology Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Prescription Dermatology Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prescription Dermatology Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Prescription Dermatology Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prescription Dermatology Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Prescription Dermatology Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prescription Dermatology Therapeutics Revenue by Type (2016-2026)
6.2 North America Prescription Dermatology Therapeutics Revenue by Application (2016-2026)
6.3 North America Prescription Dermatology Therapeutics Market Size by Country
6.3.1 North America Prescription Dermatology Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prescription Dermatology Therapeutics Revenue by Type (2016-2026)
7.2 Europe Prescription Dermatology Therapeutics Revenue by Application (2016-2026)
7.3 Europe Prescription Dermatology Therapeutics Market Size by Country
7.3.1 Europe Prescription Dermatology Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prescription Dermatology Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Prescription Dermatology Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region
8.3.1 Asia-Pacific Prescription Dermatology Therapeutics Revenue by Region (2016-2026)
8.3.2 China Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prescription Dermatology Therapeutics Revenue by Type (2016-2026)
9.2 South America Prescription Dermatology Therapeutics Revenue by Application (2016-2026)
9.3 South America Prescription Dermatology Therapeutics Market Size by Country
9.3.1 South America Prescription Dermatology Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prescription Dermatology Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Prescription Dermatology Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country
10.3.1 Middle East & Africa Prescription Dermatology Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Prescription Dermatology Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Prescription Dermatology Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prescription Dermatology Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prescription Dermatology Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prescription Dermatology Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prescription Dermatology Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Prescription Dermatology Therapeutics Product and Solutions
Table 9. Pfizer Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AbbVie Corporate Information, Head Office, and Major Competitors
Table 11. AbbVie Major Business
Table 12. AbbVie Prescription Dermatology Therapeutics Product and Solutions
Table 13. AbbVie Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Prescription Dermatology Therapeutics Product and Solutions
Table 17. Johnson & Johnson Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Prescription Dermatology Therapeutics Product and Solutions
Table 21. Novartis Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Amgen Corporate Information, Head Office, and Major Competitors
Table 23. Amgen Major Business
Table 24. Amgen Prescription Dermatology Therapeutics Product and Solutions
Table 25. Amgen Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly Prescription Dermatology Therapeutics Product and Solutions
Table 29. Eli Lilly Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Celgene Corporate Information, Head Office, and Major Competitors
Table 31. Celgene Major Business
Table 32. Celgene Prescription Dermatology Therapeutics Product and Solutions
Table 33. Celgene Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. LEO Pharma Corporate Information, Head Office, and Major Competitors
Table 35. LEO Pharma Major Business
Table 36. LEO Pharma Prescription Dermatology Therapeutics Product and Solutions
Table 37. LEO Pharma Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bausch Health Companies Corporate Information, Head Office, and Major Competitors
Table 39. Bausch Health Companies Major Business
Table 40. Bausch Health Companies Prescription Dermatology Therapeutics Product and Solutions
Table 41. Bausch Health Companies Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 43. Sun Pharmaceutical Major Business
Table 44. Sun Pharmaceutical Prescription Dermatology Therapeutics Product and Solutions
Table 45. Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Aclaris Therapeutics Corporate Information, Head Office, and Major Competitors
Table 47. Aclaris Therapeutics Major Business
Table 48. Aclaris Therapeutics Prescription Dermatology Therapeutics Product and Solutions
Table 49. Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Prescription Dermatology Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 51. Global Prescription Dermatology Therapeutics Revenue Share by Players (2019-2021)
Table 52. Breakdown of Prescription Dermatology Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Prescription Dermatology Therapeutics Players Head Office, Products and Services Provided
Table 54. Prescription Dermatology Therapeutics Mergers & Acquisitions in the Past Five Years
Table 55. Prescription Dermatology Therapeutics New Entrants and Expansion Plans
Table 56. Global Prescription Dermatology Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 57. Global Prescription Dermatology Therapeutics Revenue Share by Type (2016-2021)
Table 58. Global Prescription Dermatology Therapeutics Revenue Forecast by Type (2021-2026)
Table 59. Global Prescription Dermatology Therapeutics Revenue by Application (2016-2021)
Table 60. Global Prescription Dermatology Therapeutics Revenue Forecast by Application (2021-2026)
Table 61. North America Prescription Dermatology Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Prescription Dermatology Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Prescription Dermatology Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Prescription Dermatology Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Prescription Dermatology Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Prescription Dermatology Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Prescription Dermatology Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Prescription Dermatology Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Prescription Dermatology Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Prescription Dermatology Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Prescription Dermatology Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Prescription Dermatology Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Prescription Dermatology Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Prescription Dermatology Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Prescription Dermatology Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Prescription Dermatology Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Prescription Dermatology Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Prescription Dermatology Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Prescription Dermatology Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Prescription Dermatology Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Prescription Dermatology Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Prescription Dermatology Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Prescription Dermatology Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Prescription Dermatology Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Prescription Dermatology Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Prescription Dermatology Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Prescription Dermatology Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Prescription Dermatology Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Prescription Dermatology Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Prescription Dermatology Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prescription Dermatology Therapeutics Picture
Figure 2. Global Prescription Dermatology Therapeutics Revenue Market Share by Type in 2020
Figure 3. Fungal Infection Drugs
Figure 4. Skin Cancer Drugs
Figure 5. Acne & Rosacea Drugs
Figure 6. Psoriasis Drugs
Figure 7. Dermatitis & Seborrhea Drugs
Figure 8. Prescription Dermatology Therapeutics Revenue Market Share by Application in 2020
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Prescription Dermatology Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Prescription Dermatology Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Prescription Dermatology Therapeutics Revenue Market Share by Region (2016-2026)
Figure 15. Global Prescription Dermatology Therapeutics Revenue Market Share by Region in 2020
Figure 16. North America Prescription Dermatology Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Prescription Dermatology Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Prescription Dermatology Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Prescription Dermatology Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Prescription Dermatology Therapeutics Market Drivers
Figure 21. Prescription Dermatology Therapeutics Market Restraints
Figure 22. Prescription Dermatology Therapeutics Market Trends
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. AbbVie Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. Amgen Recent Developments and Future Plans
Figure 28. Eli Lilly Recent Developments and Future Plans
Figure 29. Celgene Recent Developments and Future Plans
Figure 30. LEO Pharma Recent Developments and Future Plans
Figure 31. Bausch Health Companies Recent Developments and Future Plans
Figure 32. Sun Pharmaceutical Recent Developments and Future Plans
Figure 33. Aclaris Therapeutics Recent Developments and Future Plans
Figure 35. Global Prescription Dermatology Therapeutics Revenue Share by Players in 2020
Figure 36. Prescription Dermatology Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Prescription Dermatology Therapeutics Revenue Market Share in 2020
Figure 38. Global Top 10 Players Prescription Dermatology Therapeutics Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Prescription Dermatology Therapeutics Revenue Share by Type in 2020
Figure 41. Global Prescription Dermatology Therapeutics Market Share Forecast by Type (2021-2026)
Figure 42. Global Prescription Dermatology Therapeutics Revenue Share by Application in 2020
Figure 43. Global Prescription Dermatology Therapeutics Market Share Forecast by Application (2021-2026)
Figure 44. North America Prescription Dermatology Therapeutics Sales Market Share by Type (2016-2026)
Figure 45. North America Prescription Dermatology Therapeutics Sales Market Share by Application (2016-2026)
Figure 46. North America Prescription Dermatology Therapeutics Revenue Market Share by Country (2016-2026)
Figure 47. United States Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Prescription Dermatology Therapeutics Sales Market Share by Type (2016-2026)
Figure 51. Europe Prescription Dermatology Therapeutics Sales Market Share by Application (2016-2026)
Figure 52. Europe Prescription Dermatology Therapeutics Revenue Market Share by Country (2016-2026)
Figure 53. Germany Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Prescription Dermatology Therapeutics Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Prescription Dermatology Therapeutics Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Share by Region (2016-2026)
Figure 61. China Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Prescription Dermatology Therapeutics Sales Market Share by Type (2016-2026)
Figure 68. South America Prescription Dermatology Therapeutics Sales Market Share by Application (2016-2026)
Figure 69. South America Prescription Dermatology Therapeutics Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Prescription Dermatology Therapeutics Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Prescription Dermatology Therapeutics Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Prescription Dermatology Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の抗肥満処方薬市場 2021：企業別、地域別、種類・用途別 The Anti-Obesity Prescription Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 世界の不眠症治療薬市場 2021：企業別、地域別、種類・用途別 The Insomnia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の頭頸部がん治療薬/治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Head and Neck Cancer Drugs/Therapeutics Market The global Head and Neck Cancer Drugs/Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界のニキビ処方薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acne Prescription Medication Market The global Acne Prescription Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
- 世界のがん治療・支持療法薬市場 2021：企業別、地域別、種類・用途別 The Cancer Therapeutics and Supportive Care Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…